The Private Investment Funds and Private Equity teams collaborated to advise Ampersand Capital Partners with the closing of its latest fund, Ampersand 2018 Limited Partnership, which raised $450 million in limited partner commitments. This fund, which is Ampersand’s ninth fund since 1992, was significantly oversubscribed and held a single close three months after launch. With this new fund, Ampersand plans to continue the firm’s strategy of making growth-oriented investments within targeted sectors of the healthcare industry.
Ampersand Capital Partners is a middle market private equity firm dedicated to growth-oriented investments in the healthcare sector. The firm focuses on both majority and minority investments in companies with $10 million to $100 million in revenues and positive EBITDA.press release.